Direction
Notre expérience vaste et variée, notre connaissance du marché et la poursuite d'un objectif commun orientent nos décisions quotidiennes et incitent nos employés à donner le meilleur d’eux-mêmes.
Mary Duseau
Président
Mary a rejoint MOLECULAR DEVICES avec plus de 25 années d’expérience sur le marché des sciences de la vie, ayant occupé des postes de responsabilité croissante dans les ventes, le marketing et la gestion commerciale.
Avant de rejoindre MOLECULAR DEVICES, elle a été vice-présidente principale, Gestion commerciale chez Leica Biosystems, une entreprise du groupe Danaher. Avant d’intégrer Danaher, Mary était PDG et présidente de Roka Bioscience et, auparavant, vice-présidente principale, Ventes chez Andor Technologies et vice-présidente mondiale, Ventes et Marketing chez PerkinElmer. Chez PerkinElmer, elle a en outre occupé le poste de responsable d’unité commerciale, Imagerie et détection, axé sur le marché de la découverte et du développement de médicaments.
Elle est titulaire d’une licence en biochimie de l’Université du Massachusetts.
Hema Sundarraj
Chief Financial Officer
Hema Sundarraj serves as Chief Financial Officer of Molecular Devices, where she leads the global Finance organization to support strategic execution, accelerate growth, and strengthen financial and operational performance.
Most recently, she was Chief Financial Officer at Phenomenex, a Danaher operating company within the Life Sciences platform. In this role, she drove strong financial results and supported growth initiatives by enhancing working capital management, leading strategic investments, and advancing the company’s IT and eCommerce capabilities. She is also known for building high-performing, engaged teams.
Previously, Hema held senior finance leadership roles at Cepheid, Applied Materials, Nanometrics, Mattson Technology, and Sunpreme. Her experience spans public and private companies, as well as growth-stage organizations.
Hema holds an MBA in Finance and Marketing from XLRI Jamshedpur and is an inactive CPA in the state of California.
Lars Hartvig Kristiansen
Vice President, Product Innovation & Strategy
Lars Hartvig Kristiansen is Vice President of Product Innovation & Strategy, responsible for leading strategic initiatives, driving innovation, and overseeing the global product management team. He leads cross-functional efforts to grow the business through M&A, licensing, and partnerships, while guiding strategic planning and execution across the company.
Lars brings over a decade of experience in life sciences and management consulting. At Agilent Technologies, he held senior roles across strategy, operations, and M&A, including leading strategic growth initiatives for the $4B Life Sciences group and most recently serving as General Manager, running the Global Automation Solutions P&L. He holds Bachelor’s and Master’s degrees in Engineering from Aalborg University, with a focus on Technology Management and Supply Chain.
Dan Green
Vice-président, Recherche et Développement
Krishnapal Solanki
Vice president, DBS
En tant que vice-président, DBS, Krishnapal supervise tous les efforts d’amélioration continue à l’échelle mondiale dans toutes les fonctions. Krishnapal a rejoint MOLECULAR DEVICES en novembre 2021 avec plus de 13 années d’expérience à la direction de diverses fonctions au sein de 3 sociétés d’exploitation différentes du groupe Danaher.
Le parcours de Krishnapal chez Danaher a commencé en tant que client (recherche en sciences de la vie) ; il a ensuite intégré Danaher chez Leica Microsystems en tant que principal technicien de service sur le terrain et a occupé divers postes progressifs, tels que superviseur régional des opérations de service sur le terrain, responsable de la croissance pour les Amériques, responsable principal des ventes et du marketing chez Cepheid et, plus récemment, directeur de l’innovation DBS chez MOLECULAR DEVICES. Krishnapal est compétent et certifié dans les outils d’amélioration des processus de Danaher, tels que DM/VM, la gestion de l’entonnoir et PSP, et a facilité et dirigé des ateliers Kaizen pour des équipes transversales dans diverses filiales de Danaher. Son expertise professionnelle inclut l’installation et l’entretien des 3 moteurs DBS (commercial, innovation et service) pour stimuler la croissance de toute l’organisation. Krishnapal est également impliqué dans les activités relatives à la diversité, l’équité et l’inclusion et a été responsable de l’engagement des membres chez Asian Descent + Friends ARG chez Danaher depuis 2021-2022.
Krishnapal est titulaire d’un Master en sciences, d’un diplôme en ingénierie biomédicale, obtenu à l’UT Arlington et au SW Medical Center de Dallas. Il est titulaire d’une licence en ingénierie biomédicale qu’il a obtenue en Inde.
Lakshmi Sailaja Eleswarapu
Vice President, IT
As Vice President of IT for SCIEX, Molecular Devices, and Danaher Life Sciences, Lakshmi Eleswarapu champions global IT strategy, fostering technological innovation and organizational excellence. Her role extends to supporting the Danaher Life Sciences Innovation Group (LSIG) commercial team and contributing to the L1 team at Molecular Devices. Her tenure includes significant achievements in business transformation, M&A IT integrations, and diversity initiatives. Lakshmi's career spans 26 years in IT, with the last 16 years dedicated to Danaher, positioning her to drive future innovation and growth.
Lakshmi holds a Bachelor’s in Mathematics with Honors from SSSIHL University (India) and a Master’s in Computer Applications from Osmania University (India).
Ray Li
Vice President of Global Operations
Tracy Clarke
Vice President of Service
Tracy Clarke, Vice President of Service, brings over 30 years of experience in the laboratory and medical industry to Molecular Devices. With a remarkable 17-year tenure at Leica Biosystems, Tracy excels in building high-performing teams, managing complex projects, and driving continuous improvement. As Senior Director of Service at Leica, she led a team of 210 professionals, managed a $96M P&L, and consistently drove customer satisfaction and revenue growth. Tracy is committed to enhancing our customers’ experience, building service capabilities, fostering strong cross-functional relationships, and promoting an inclusive culture.
Tracy Clarke, holds a master’s degree in Veterinary Medical Science and a Bachelor’s degree in Molecular Biology & Cell Science from the University of Florida.
Yang Shi
Vice President, Global Commercial
Yang Shi, Ph.D., MBA, is Vice President of Global Commercial at Molecular Devices, where he leads a worldwide team spanning Sales, Field Applications, Customer Service, and Sales Operations. He brings extensive commercial leadership experience from across Danaher, including roles at SCIEX, Phenomenex, and Integrated DNA Technologies (IDT).
Most recently, he served as Vice President of Americas Sales at IDT and previously as Vice President of Global Sales at Phenomenex. Earlier in his career, Yang advanced scientific innovation as a Senior Scientist with Waters Corporation, Thermo Fisher Scientific, and the Sanford Burnham Institute.
Yang holds a Ph.D. in Chemical Engineering from Yale University, an MBA from the University of Massachusetts–Amherst, and B.S. and M.S. degrees in Biochemical Engineering from Tianjin University.